• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Brandt

Brandt

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Enanta Pharmaceuticals Announces U.S. Regulatory Approval of TECHNIVIE™ (ombitasvir, paritaprevir and ritonavir) tablets

    Enanta Pharmaceuticals Announces U.S. Regulatory Approval of TECHNIVIE™ (ombitasvir, paritaprevir and ritonavir) tablets

  2. EmblemHealth and Tabula Rasa HealthCare Announce New Medication Therapy Management Program

    EmblemHealth and Tabula Rasa HealthCare Announce New Medication Therapy Management Program

  3. 'Acropolis Now' -- stocks are toast

    'Acropolis Now' -- stocks are toast

  4. Questions for Buffett

    Morningstar's Gregg Warren, one of three analysts who will be quizzing Warren Buffett and Charlie Munger in Omaha, describes how he narrows down his list of questions to just six.

  5. What Questions Should Be Asked of Berkshire This Year?

    Morningstar's Gregg Warren, who will be on the analyst panel at this year's meeting, details the questions he hopes Buffett and Munger will address.

  6. French Election impact on the EU

    For more complete information on the American Independence Funds, you can obtain a prospectus containing complete information for the funds by calling 866-410-2006, or by visiting www.aifunds.com. You should read and consider the fund’s investment objectives, risks, charges,and expenses carefully ...

  7. Questions We'd Like to Hear at Berkshire's Annual Meeting

    We'd like to see Buffett address future acquisitions, his take on the economy, the firm's succession plan, and more at this year's annual meeting.

  8. Hussman Goes International

    Plus, American Fund shareholders appeal excessive-fee decision, and more.

  9. Target-Date Ads in SEC's Cross Hairs

    Plus, Oppenheimer fund gets a facelift, and more.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.